Treatment of refractory obstetric antiphospholipid syndrome: the state of the art and new trends in the therapeutic management.
about
Obstetrical antiphospholipid syndrome: from the pathogenesis to the clinical and therapeutic implicationsFondaparinux as alternative anticoagulant to warfarin or low-molecular-weight heparin for recurrent venous thrombosis.Current treatment of antiphospholipid syndrome: lights and shadows.Recurrent miscarriage: causes, evaluation and management.Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation?Response to Plasmapheresis Measured by Angiogenic Factors in a Woman with Antiphospholipid Syndrome in Pregnancy.Pregnancy morbidity in antiphospholipid syndrome: what is the impact of treatment?Antiphospholipid syndrome: an update.Immunotherapeutic strategies in antiphospholipid syndrome.Additional Treatments for High-Risk Obstetric Antiphospholipid Syndrome: a Comprehensive Review.Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy.Tumor Necrosis Factor-Alpha and Pregnancy: Focus on Biologics. An Updated and Comprehensive Review.Detrimental roles of TNF-alpha in the antiphospholipid syndrome and de novo synthesis of antiphospholipid antibodies induced by biopharmaceuticals against TNF-alpha.Thrombophilia and Pregnancy
P2860
Q26998188-78294A6E-F5E9-4719-A2D7-37EF810E8F77Q33413002-7C6FC4E0-03FA-4ECE-AF0B-3ADA311EA540Q33423959-EF542E41-CCCA-4ED2-93C0-2A41C518EE62Q34462726-0C463743-7D8A-4745-BFE1-C53DC2829AD4Q35915182-53E1EE31-CDF6-416B-BDE3-D27C3DB3E6B4Q36043513-AC7E1363-33A4-46C5-A84F-731A20A58B6AQ38175887-F811E652-89BD-47AA-B564-BC49EB4148FEQ38410376-72F4C1C0-9836-4E97-B2E0-9704EDCB0555Q38826804-73003BD6-25F0-48EA-B208-84E9737D11E8Q38876334-428685F1-8AE5-4ECB-8F9F-EEA9D148EFF9Q38891094-B0978200-B47E-4C67-83C1-2D4D5BF07981Q39039141-81DF2B5C-8F1B-4D60-8142-9704EE3C0417Q48192268-BA430353-7E83-4B78-A651-23AEC8CB8E31Q53101748-13CFCBC3-B4A8-4079-9C2E-DA397F25CC84
P2860
Treatment of refractory obstetric antiphospholipid syndrome: the state of the art and new trends in the therapeutic management.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Treatment of refractory obstet ...... in the therapeutic management.
@ast
Treatment of refractory obstet ...... in the therapeutic management.
@en
Treatment of refractory obstet ...... in the therapeutic management.
@nl
type
label
Treatment of refractory obstet ...... in the therapeutic management.
@ast
Treatment of refractory obstet ...... in the therapeutic management.
@en
Treatment of refractory obstet ...... in the therapeutic management.
@nl
prefLabel
Treatment of refractory obstet ...... in the therapeutic management.
@ast
Treatment of refractory obstet ...... in the therapeutic management.
@en
Treatment of refractory obstet ...... in the therapeutic management.
@nl
P2860
P356
P1433
P1476
Treatment of refractory obstet ...... in the therapeutic management
@en
P2093
J Alijotas-Reig
P2860
P356
10.1177/0961203312465782
P577
2012-11-14T00:00:00Z